Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1949]
News [3653]
Articles [96]
Editorials [5]
Conferences [157]
elearning [19]
New review calls for age-specific immunotherapy in childhood brain tumours
New review calls for age-specific immunotherapy in childhood brain tumours
Lung cancer rewires immune cells in the bone marrow to weaken body’s defenses
Lung cancer rewires immune cells in the bone marrow to weaken body’s defenses
'Bottlebrush' particles deliver big chemotherapy directly to cancer cells
'Bottlebrush' particles deliver big chemotherapy directly to cancer cells
WCLC 2025: Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors
WCLC 2025: Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with...
WCLC 2025: Circulating tumour DNA may guide immunotherapy use in limited-stage SCLC, new study shows
WCLC 2025: Circulating tumour DNA may guide immunotherapy use in limited-stage SCLC, new study shows
WCLC 2025: New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer
WCLC 2025: New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer
WCLC 2025: PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC
WCLC 2025: PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR...
WCLC 2025: Clinical trial suggests immunotherapy before surgery is a potential new treatment for rare cancer
WCLC 2025: Clinical trial suggests immunotherapy before surgery is a potential new treatment for rare cancer
WCLC 2025: First-ever clinical trial demonstrates safety, molecular readout and promise of pre- and post-surgery immunotherapy combination for patients with operable mesothelioma
WCLC 2025: First-ever clinical trial demonstrates safety, molecular readout and promise of pre- and post-surgery...
GLP-1 receptor agonists improve lung cancer outcomes
GLP-1 receptor agonists improve lung cancer outcomes

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation